Sales and Marketing

Showing 15 posts of 11527 posts found.

Novo Nordisk invests in haemophilia with Denmark facility

May 5, 2015 Manufacturing and Production, Sales and Marketing Novo Nordisk, diabetes, haemophilia, novoseven

Novo Nordisk is spending around $225 million on a new facility in Kalundborg, Denmark to produce active pharmaceutical ingredients for haemophilia …

Working Life: AstraZeneca’s Jonathan Day

May 5, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Jonathan Day, Working Life

 How did you find your way into your current role? By way of background, I trained in medicine at the …

Two consultants join RSA’s UK team

May 5, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Agata Grzeszczuk, Andy Theodorou, rsa

Life sciences recruitment firm RSA has appointed two new consultants to its UK executive search team.   Agata Grzeszczuk (pictured) takes …

Takeda pays $2.7 billion to settle Actos lawsuits

May 1, 2015 Sales and Marketing Actos, FDA, Takeda, bladder, lilly, pioglitazone, type 2

Takeda has agreed to pay $2.7 billion to finally settle thousands of US lawsuits claiming its diabetes drug Actos can …

Martindale Pharma expands business in Asia-Pacific

May 1, 2015 Manufacturing and Production, Sales and Marketing Singapore, aft pharma, martindale

UK-based speciality firm Martindale Pharma is to expand its business in the Asia-Pacific market with the appointment of AFT Pharmaceuticals …

GSK sees FDA clearance for asthma drug

May 1, 2015 Sales and Marketing Breo Ellipta, FDA, GSK, Theravance

GlaxoSmithKline and Theravance’s Breo Ellipta inhaler has been approved by the FDA to treat asthma in adults. Whilst the once-daily treatment …

Virgo Consumer Health & Wellbeing hires associate director

May 1, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kirsty McKinnon, Virgo

Virgo Consumer Health & Wellbeing has appointed Kirsty McKinnon to lead the division’s personal care sector. McKinnon joins the firm …

Profits fall at Bayer but new drugs see growth

May 1, 2015 Sales and Marketing Bayer, Eliquis, Eylea, Renegeron, Xarelto, apixaban

Bayer’s pharmaceutical revenues have continued their upward trajectory in the first quarter of 2015 thanks to new products, although this …

Apple research apps to require ethics board approval

April 30, 2015 Sales and Marketing Apple, BMJ, FDA, GP, researchkit

New guidelines will require apps developed for Apple’s ResearchKit health platform to be approved by an independent ethics board. The …

Perrigo bats away raised Mylan bid

April 30, 2015 Sales and Marketing Mylan, Perrigo, Teva, Vigodman, merger

Perrigo has rejected an updated $34.1 billion takeover bid from Mylan, whilst Teva has also written an open letter in …

NHS ‘close to breaking point’

April 30, 2015 Medical Communications, Sales and Marketing BMJ, Godlee, Kings Fund, NHS, king's fund

England’s NHS is ‘stretched close to breaking point’ and the next five years are likely to be the most challenging …

FDA waves through generic BMS antipsychotic

April 30, 2015 Manufacturing and Production, Sales and Marketing Alembic, BMS, FDA, Hetero and Torrent Pharmaceuticals, Teva

The FDA has approved four generic versions of Bristol-Myers Squibb’s top selling Abilify, an atypical antipsychotic drug approved to treat …

Recipharm appoints general manager for Italian unit

April 30, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Giorgio Bruno, Recipharm

Contract development and manufacturing organisation Recipharm has confirmed that Dr Giorgio Bruno has been appointed general manager of Recipharm Italia. In …

Pharma accused of hiding behind regulation and undermining NICE

April 29, 2015 Medical Communications, Sales and Marketing NHS, NICE, Royal Society of Medicine, UK, brett wells, health, pharma

University of York health economists have argued that pharma regulation is not evidence-based, lacks accountability and undermines NICE. Writing in …

Pfizer posts second consecutive quarterly income decline

April 29, 2015 Sales and Marketing 2015, Pfizer, Q1, first quarter

Pfizer made 4% less revenue in the first quarter of 2015 compared with the same period last year, the company’s …
The Gateway to Local Adoption Series

Latest content